HPP737 in Adult Patients With Plaque Psoriasis

NCT07712731 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

607

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HPP737
DRUG: Placebo matching HPP737
DRUG: Apremilast
DRUG: Placebo matching Apremilast

Sponsor

Newsoara Biopharma Co., Ltd.